Skip to main content Skip to navigation

The State of Financial Crime 2024: Download our latest research

FinCEN Advances No-Action Letter Proposal to Boost AML Innovation

Latest News

The Financial Crimes Enforcement Network (FinCEN) has issued an Advance Notice of Proposed Rulemaking (ANPRM) for a no-action letter process, which would enable regulated entities to receive feedback on whether certain services, products, and/or actions would breach federal anti-money laundering (AML) laws and regulations. The ANPRM follows a report submitted to Congress last year which evaluates the pros/cons of a no-action letter process. 

FinCEN was required to consider a no-action letter process under Section 6305(a) of the Anti-Money Laundering Act of 2020. In its report to Congress, FinCEN stated that a no-action letter process could help encourage innovation in financial services for anti-money laundering/combating the financing of terrorism (AML/CFT) and compliance functions.

Three federal financial services agencies currently issue no-action letters, including the  Securities Exchange Commission (SEC), the Consumer Financial Protection Bureau (CFPB), and Commodity Futures Trading Commission (CFTC). 

FinCEN is now soliciting feedback on its proposed no-action process until August 5, 2022.

No-action letters: Pros and cons

In its report to Congress, FinCEN analyzed whether a formal no-action letter process would help mitigate or accentuate illicit finance risks in the US. While both pros and cons of the process were detailed, FinCEN concluded the implementation of a no-action process would be useful to supplement the existing forms of regulatory relief and guidance the agency already provides and enhance the overall effectiveness of AML/CFT frameworks implemented by financial institutions.

FinCEN noted in the report that a no-action letter process could spur communication between the regulator and the regulated parties, offering a quicker form of guidance and mitigating the spread of varying interpretations of regulations. Similar to the Financial Conduct Authority (FCA) providing a supportive sandbox environment, the no-action letter process is described by FinCEN as an “expedited dialogue” that will allow regulated entities to seek confirmation that FinCEN will not pursue an enforcement action against a proposed activity.

However, the report to Congress also states it is aware the no-action letter process could accentuate illicit finance risk if an entity were to submit false, misleading, or incomplete information to FinCEN. Further, a submitting party could use their no-action letter as a means of avoiding regulatory scrutiny for additional conduct not considered by FinCEN in its initial decision.

Key takeaways 

FinCEN currently offers only two forms of regulatory guidance: administrative rulings and exceptive or exemptive relief. Both forms have their limitations and are often not made public. In contrast, a no-action letter process could provide regulated industries with more certainty regarding FinCEN’s position on their prospective activities, which could aid companies looking to utilize innovative processes that may not have been anticipated by older laws and regulations. 

Compliance staff should ensure they are familiar with FinCEN’s report to Congress, noting the feedback that was submitted by government agencies in the initial consultation. Any feedback on the no-action letter process should be submitted to FinCEN by the deadline of August 5, 2022. 

The Anti-Money Laundering Act of 2020 (AMLA)

From changes in the customer due diligence process to new penalties for misrepresenting or withholding information, uncover the full extent of the AMLA and what it means for your organization.

Read the guide

Originally published 10 June 2022, updated 13 June 2022

Disclaimer: This is for general information only. The information presented does not constitute legal advice. ComplyAdvantage accepts no responsibility for any information contained herein and disclaims and excludes any liability in respect of the contents or for action taken based on this information.

Copyright © 2024 IVXS UK Limited (trading as ComplyAdvantage).